Back to News
Market Impact: 0.1
Aptevo Therapeutics Inc. Amends Rights Agreement to Extend Expiration Date to October 23, 2027
Source: Nasdaq
Management & GovernanceLegal & Litigation
On October 23, 2026, Aptevo Therapeutics Inc. entered into Amendment No. 6 to its Rights Agreement, dated November 8, 2020, with Broadridge Corporate Issuer Solutions, LLC as rights agent. The provided article text does not specify the amendment’s terms or effects.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
- Meta shares are down 9% this week. Here's why Mike Khouw is buying now
- ‘It wasn’t me, and I don’t think it was Elon’: Trump and his cabinet send mixed messages about what led to Ukraine’s Starshield interruptions
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%